Literature DB >> 12384595

Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition.

Ningwen Tai1, Yuyan Ding, John C Schmitz, Edward Chu.   

Abstract

Previous studies have shown that human dihydrofolate reductase (DHFR) acts as an RNA-binding protein, in which it binds to its own mRNA and, in so doing, results in translational repression. In this study, we used RNA gel mobility shift and nitrocellulose filter-binding assays to further investigate the specificity of the interaction between human DHFR protein and human DHFR mRNA. Site-directed mutagenesis was used to identify the critical amino acid residues on DHFR protein required for RNA recognition. Human His-Tag DHFR protein specifically binds to human DHFR mRNA, while unrelated proteins including thymidylate synthase, p53 and glutathione-S-transferase were unable to form a ribonucleoprotein complex with DHFR mRNA. The Cys6 residue is essential for RNA recognition, as mutation at this amino acid with either an alanine (C6A) or serine (C6S) residue almost completely abrogated RNA-binding activity. Neither one of the cysteine mutant proteins was able to repress the in vitro translation of human DHFR mRNA. Mutations at amino acids Ile7, Arg28 and Phe34, significantly reduced RNA-binding activity. An RNA footprinting analysis identified three different RNA sequences, bound to DHFR protein, ranging in size from 16 to 45 nt, while a UV cross-linking analysis isolated an approximately 16 nt RNA sequence bound to DHFR. These studies begin to identify the critical amino acid residues on human DHFR that mediate RNA binding either through forming direct contact points with RNA or through maintaining the protein in an optimal structure that allows for the critical RNA-binding domain to be accessible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384595      PMCID: PMC137126          DOI: 10.1093/nar/gkf562

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Polyoma virus and cyclic AMP-mediated control of dihydrofolate reductase mRNA abundance in methotrexate-resistant mouse fibroblasts.

Authors:  R E Kellems; V B Morhenn; E A Pfendt; F W Alt; R T Schimke
Journal:  J Biol Chem       Date:  1979-01-25       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Regulating the fate of mRNA: the control of cellular iron metabolism.

Authors:  R D Klausner; T A Rouault; J B Harford
Journal:  Cell       Date:  1993-01-15       Impact factor: 41.582

4.  Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis.

Authors:  T Nakano; H T Spencer; J R Appleman; R L Blakley
Journal:  Biochemistry       Date:  1994-08-23       Impact factor: 3.162

5.  The intracellular content of dihydrofolate reductase: possibilities for control and implications for chemotherapy.

Authors:  K F Bastow; R Prabhu; Y C Cheng
Journal:  Adv Enzyme Regul       Date:  1984

Review 6.  Regulation of ferritin and transferrin receptor mRNAs.

Authors:  E C Theil
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

7.  Control of cellular gene expression during adenovirus infection: induction and shut-off of dihydrofolate reductase gene expression by adenovirus type 2.

Authors:  S S Yoder; B L Robberson; E J Leys; A G Hook; M Al-Ubaidi; C Y Yeung; R E Kellems; S M Berget
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

8.  Cell cycle regulation of dihydrofolate reductase mRNA metabolism in mouse fibroblasts.

Authors:  S L Hendrickson; J S Wu; L F Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  The effect of polyoma virus, serum factors, and dibutyryl cyclic AMP on dihydrofolate reductase synthesis, and the entry of quiescent cells into S phase.

Authors:  T M Gudewicz; V B Morhenn; R E Kellems
Journal:  J Cell Physiol       Date:  1981-07       Impact factor: 6.384

10.  Determinants of trimetrexate lethality in human colon cancer cells.

Authors:  J L Grem; D M Voeller; F Geoffroy; E Horak; P G Johnston; C J Allegra
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

View more
  12 in total

1.  The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism.

Authors:  Giulia Guiducci; Alessio Paone; Angela Tramonti; Giorgio Giardina; Serena Rinaldo; Amani Bouzidi; Maria C Magnifico; Marina Marani; Javier A Menendez; Alessandro Fatica; Alberto Macone; Alexandros Armaos; Gian G Tartaglia; Roberto Contestabile; Alessandro Paiardini; Francesca Cutruzzolà
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

2.  Optimization of NMR spectroscopy of encapsulated proteins dissolved in low viscosity fluids.

Authors:  Nathaniel V Nucci; Bryan S Marques; Sabrina Bédard; Jakob Dogan; John M Gledhill; Veronica R Moorman; Ronald W Peterson; Kathleen G Valentine; Alison L Wand; A Joshua Wand
Journal:  J Biomol NMR       Date:  2011-07-12       Impact factor: 2.835

3.  The former annotated human pseudogene dihydrofolate reductase-like 1 (DHFRL1) is expressed and functional.

Authors:  Gráinne McEntee; Stefano Minguzzi; Kirsty O'Brien; Nadia Ben Larbi; Christine Loscher; Ciarán O'Fágáin; Anne Parle-McDermott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-26       Impact factor: 11.205

4.  Identification of endogenous ligands bound to bacterially expressed human and E. coli dihydrofolate reductase by 2D NMR.

Authors:  Gira Bhabha; Lisa Tuttle; Maria A Martinez-Yamout; Peter E Wright
Journal:  FEBS Lett       Date:  2011-10-20       Impact factor: 4.124

5.  Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).

Authors:  Peter C Gareiss; Krzysztof Sobczak; Brian R McNaughton; Prakash B Palde; Charles A Thornton; Benjamin L Miller
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

6.  Characterization of a cis-acting regulatory element in the protein-coding region of human dihydrofolate reductase mRNA.

Authors:  Ningwen Tai; John C Schmitz; Tian-min Chen; Edward Chu
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

7.  miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.

Authors:  Bo Song; Yuan Wang; Kenji Kudo; Elaine J Gavin; Yaguang Xi; Jingfang Ju
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

8.  A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines.

Authors:  Renee N Donahue; Brynn B Duncan; Terry J Fry; Barry Jones; William W Bachovchin; Christopher P Kiritsy; Jack H Lai; Wengen Wu; Peng Zhao; Yuxin Liu; Kwong-Yok Tsang; James W Hodge
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

9.  Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation.

Authors:  David Rushworth; Amber Mathews; Amir Alpert; Laurence J N Cooper
Journal:  J Biol Chem       Date:  2015-08-04       Impact factor: 5.157

10.  A protein shuttle system to target RNA into mitochondria.

Authors:  François Sieber; Antonio Placido; Samira El Farouk-Ameqrane; Anne-Marie Duchêne; Laurence Maréchal-Drouard
Journal:  Nucleic Acids Res       Date:  2011-05-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.